Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations clinical trials

Explore recruiting metastatic colorectal cancer that is resistant to the currently approved methods of treatment is recognized as a serious threat to public health worldwide research efforts in recent years have become increasingly geared towards discovering and developing new treatment regimens with modes of action distinct from those of established agents and with the ability to target subclasses of colorectal cancer such as those associated with ras mutations clinical trials.

Also recruiting in Europe

Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized Phase 2 Study of ompenaclid versus placebo in combination with FOLFIRI plus bevacizumab in patients with previously treated RAS mutant advanced or metastatic colorectal cancer

Spain, Belgium, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations trials by city

Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Toronto Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Vancouver Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Montreal Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Calgary Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Edmonton Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Ottawa Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Winnipeg Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Quebec City Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Hamilton Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Kitchener Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in London Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Halifax Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in New York Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Los Angeles Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Chicago Metastatic Colorectal Cancer That Is Resistant To The Currently Approved Methods Of Treatment Is Recognized As A Serious Threat To Public Health Worldwide Research Efforts In Recent Years Have Become Increasingly Geared Towards Discovering And Developing New Treatment Regimens With Modes Of Action Distinct From Those Of Established Agents And With The Ability To Target Subclasses Of Colorectal Cancer Such As Those Associated With Ras Mutations in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease